CHMP finder, at produktoplysningerne for PROCOMVAX bør ændres af hensyn til fortsat sikker og effektiv klinisk anvendelse af følgende grunde:
The CHMP is of the Opinion that the Product Information of PROCOMVAX, should be varied in order to maintain the safe and effective clinical use for the following reasons: